Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers

Exclusion Criteria

• •Patients with comorbidities that may interfere with the interpretation of the results (CKD in dialysis phase, Autoimmune diseases, uncontrolled Diabetes Mellitus (DM), symptomatic Heart Failure (CHF), HIV positive, positive serology for hepatitis B and C);
• •Patients requiring multiple blood transfusions (4 or more blood components for the same period or cause);
• •Pregnant women;
• •First-line treatment in another institution;
• •Diffuse transformed Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma